Licensed Practical Nurse in Tewksbury, MA Accepting Medicare

8 Licensed Practical Nurse nurses found. Showing 1 - 8

Natacha Dorastin, LPN Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 51 Stickney Rd, Tewksbury, MA 01876 Phone: 617-888-8647

Robinah Nabasaggi, Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 1057 South St, Tewksbury, MA 01876 Phone: 978-930-0863

Grace Poirier, Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 94 Carolina Rd, Tewksbury, MA 01876 Phone: 978-658-1864

Maureen Lee Guild, Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 30 Meredith Rd, Tewksbury, MA 01876 Phone: 781-799-4299

Juliann Stadnyck, LPN Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 1208 Ames Hill Dr, Tewksbury, MA 01876 Phone: 978-880-0606

Lerrea Mengata, Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 227 Foster Rd, Tewksbury, MA 01876 Phone: 857-249-8804

Mrs. Sandra Lee Proulx, LPN Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 10 Arnold Rd, Tewksbury, MA 01876 Phone: 978-657-5268

Mabel Byakika, LPN Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 2208 Archstone Ave, Tewksbury, MA 01876 Phone: 978-221-6691    Fax: 978-221-6691

News Archive

Phase 1 clinical trial results evaluating ARIAD's investigational mTOR inhibitor ridaforolimus

ARIAD Pharmaceuticals, Inc. (Nasdaq: ARIA) today announced data from a Phase 1 clinical trial evaluating oral ridaforolimus, its investigational mTOR inhibitor, in combination with bevacizumab (Avastin®) in heavily pretreated patients with refractory metastatic solid tumors. The data were presented at the Joint Multidisciplinary Congress of the 15th annual European Cancer Organization (ECCO) and the 34th annual European Society of Medical Oncology (ESMO) taking place in Berlin, Germany.

DNA may be used to predict lifespan: Study

Researchers may soon be able to predict how long a person will live based on their genetics. This could result from the discovery by a University of Glasgow team in Scotland showing that telomere length on the ends of DNA in their genes in early-life predicts life spans.

Changes in national diets linked to dramatic rise in AD prevalence in Japan and developing countries

In a paper just published electronically in the Journal of Alzheimer's Disease, dramatic increases in Alzheimer's disease in Japan and significant increases in developing countries are linked to changes in national diets.

TraceLink, Catalent announce partnership to improve production visibility for customers

TraceLink, Inc., the provider of the World's 1st Industry-Wide Supply Collaboration Network, and Catalent Pharma Solutions, Inc., a leading provider of innovative drug development and delivery solutions for pharmaceutical, biotechnology and consumer healthcare companies, today announced a partnership that will improve production visibility for Catalent customers across their entire manufacturing and packaging product lifecycle.

Anti-cancer prodrug can benefit cancer patients

Unlike conventional cancer drugs that attack and kill cancer cells directly, anti-cancer immunotherapy, which kills cancer cells by strengthening the body's immunity, is a novel type of cancer treatment currently attracting increased attention. Unfortunately, a minority of cancer patients who have some degree of pre-existing immunity only benefit from anti-cancer immunotherapy.

Read more Medical News

› Verified 4 days ago